Selective serotonin reuptake inhibitors are the most commonly chosen antidepressants in patients with Parkinson\'s disease (PD). The aim of our study was to assess the influence of fluoxetine (Flu) on motor functions in .patients with PD. In this prospective, controlled, open-label study, 18 patients with PD and mild depression (10
|
|||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||


